NKGen Biotech (NKGN) Stock Statistics & Valuation Metrics

NKGen Biotech has a market cap or net worth of $7.84M. The enterprise value is $46.02M.

NKGen Biotech has 130,602,230 shares outstanding. The number of shares has decreased by -2.65% in one year.

NKGen Biotech’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is -112358.33%.

The current PE Ratio of NKGen Biotech is <0.1. NKGen Biotech’s PEG ratio is 0.00598.

In the last 12 months, NKGen Biotech had revenue of 0.00 and earned -44.29M in profits. Earnings per share was -1.54.

In the last 12 months, operating cash flow was -19.65M and capital expenditures -52.00K, giving a free cash flow of -19.70M billion.

NKGen Biotech pays an annual dividend of ―, resulting in a dividend yield of ―

NKGen Biotech upcoming earnings date is ―, ―.

NKGen Biotech as a current ratio of 0.00, with Debt / Equity ratio of -75.88%

In the past 12 months, NKGen Biotech has paid 53.00K in taxes.

NKGen Biotech EV to EBITDA ratio is -0.70, with an EV/FCF ratio of -0.90.

NKGen Biotech has $6.00K in cash and marketable securities with $38.19M in debt, giving a net cash position of -$38.19M billion.

Gross margin is 50.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for NKGen Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―